These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 37192333)
21. Safety Assessment of PCA (2-Pyrrolidone-5-Carboxylic Acid) and Its Salts as Used in Cosmetics. Fiume MM; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2019; 38(2_suppl):5S-11S. PubMed ID: 31522652 [TBL] [Abstract][Full Text] [Related]
24. Amended Safety Assessment of Fatty Acyl Sarcosines and Sarcosinate Salts as Used in Cosmetics. Fiume MM; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2021 Oct; 40(2_suppl):117S-133S. PubMed ID: 34225481 [TBL] [Abstract][Full Text] [Related]
25. Safety Assessment of Bovine Milk Proteins and Protein Derivatives as Used in Cosmetics. Burnett CL; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B Int J Toxicol; 2022 Aug; 41(2_suppl):43S-56S. PubMed ID: 35510869 [TBL] [Abstract][Full Text] [Related]
27. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. Elmore AR Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915 [TBL] [Abstract][Full Text] [Related]
28. Amended Safety Assessment of Persulfates as Used in Cosmetics. Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B Int J Toxicol; 2022 Dec; 41(3_suppl):5-21. PubMed ID: 36165404 [TBL] [Abstract][Full Text] [Related]
29. Safety Assessment of Cross-Linked Alkyl Acrylates as Used in Cosmetics. Fiume MM; Heldreth B; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA Int J Toxicol; 2017; 36(5_suppl2):59S-88S. PubMed ID: 29025328 [TBL] [Abstract][Full Text] [Related]
30. Safety Assessment of Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2022 Jun; 41(1_suppl):44S-60S. PubMed ID: 35531605 [TBL] [Abstract][Full Text] [Related]
31. Safety Assessment of Silk Protein Ingredients as Used in Cosmetics. Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2020; 39(3_suppl):127S-144S. PubMed ID: 33203267 [TBL] [Abstract][Full Text] [Related]
32. Safety Assessment of Alkyl PEG Sulfosuccinates as Used in Cosmetics. Johnson W; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA Int J Toxicol; 2015 Sep; 34(2 Suppl):70S-83S. PubMed ID: 26362121 [TBL] [Abstract][Full Text] [Related]
33. Final safety assessment of thiodipropionic acid and its dialkyl esters as used in cosmetics. Diamante C; Fiume MZ; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Alan Andersen F Int J Toxicol; 2010 Jul; 29(4 Suppl):137S-50S. PubMed ID: 20634504 [TBL] [Abstract][Full Text] [Related]
34. Safety assessment of alkyl benzoates as used in cosmetics. 'Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA Int J Toxicol; 2012; 31(6 Suppl):342S-72S. PubMed ID: 23283706 [TBL] [Abstract][Full Text] [Related]
35. Safety Assessment of Apple-Derived Ingredients as Used in Cosmetics. Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2023 Jun; 42(1_suppl):36S-56S. PubMed ID: 36809230 [TBL] [Abstract][Full Text] [Related]
36. Safety Assessment of Ethers and Esters of Ascorbic Acid as Used in Cosmetics. Johnson W; Boyer IJ; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B Int J Toxicol; 2022 Aug; 41(2_suppl):57S-75S. PubMed ID: 35549580 [TBL] [Abstract][Full Text] [Related]
37. Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics. Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; Alan Andersen F Int J Toxicol; 2010 Jul; 29(4 Suppl):162S-86S. PubMed ID: 20634506 [TBL] [Abstract][Full Text] [Related]
38. Safety Assessment of Eucalyptus globulus (Eucalyptus)-Derived Ingredients as Used in Cosmetics. Becker LC; Akinsulie A; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B Int J Toxicol; 2023 Jun; 42(1_suppl):57S-92S. PubMed ID: 37010839 [TBL] [Abstract][Full Text] [Related]
39. Safety Assessment of Saccharide Esters as Used in Cosmetics. Scott LN; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B Int J Toxicol; 2021 Oct; 40(2_suppl):52S-116S. PubMed ID: 34514895 [TBL] [Abstract][Full Text] [Related]
40. Safety Assessment of Skin and Connective Tissue-Derived Proteins and Peptides as Used in Cosmetics. Burnett CL; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Heldreth B Int J Toxicol; 2022 Aug; 41(2_suppl):21S-42S. PubMed ID: 35668614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]